CAS: 15301-69-6; 2-(Piperidin-1-yl)Ethyl 3-Methyl-4-Oxo-2-Phenyl-4H-Chromene-8-Carboxylate

该化合物是一种合成化合物,主要用作尿道抗沙司剂,其特点是能够缓解膀胱炎和相关的不适,从而有利于治疗过活性膀胱和间细胞炎等疾病;氟化氯酸盐的化学结构包括一个苯基组和一个管状动物,有助于其药理特性;它的作用是抑制乙酰胆碱酯对光滑肌肉的动作,从而减少膀胱的非自愿收缩;氟化氯酸盐通常是口服的,在胃肠道中吸收良好;其药用植物表明一种中度半衰期,允许有效的剂量治疗;常见的副作用可能包括口干,头晕和胃肠紊乱;同任何药物一样,它至关重要的是考虑甲状腺素与其他药物的反作用和可能的相互作用;

结构式图片

MSDS等安全信息

上下游产品

CAS号91099-99-9 Benzoic acid, 2... | CAS号98-88-4 苯甲酰氯

合成工艺路线路线简述

    📜β-Piperidinoethyl 6-Chloro-3-Methylflavone-8-Carboxylate置于palladium-Carbon Catalyst Sodium Acetate体系中,用 异丙醇 用作溶剂,以3.8 G (96.2%)的收率获得黄酮哌酯
    参考文献:Halo-Containing 3-Methylflavone-8-Carboxylic Acid Derivatives
    标题:Halo-Containing 3-Methylflavone-8-Carboxylic Acid Derivatives
    摘要:这项发明涉及由式(1)表示的3-甲基黄酮-8-羧酸衍生物 ##str1## 其中r代表氢原子,较低的烷基基团或基团 ##str2## (其中r.Sup.1和r.Sup.2代表较低的烷基基团或r.Sup.1和r.Sup.2,当与它们连接的氮原子一起时,可以形成具有或不具有介入杂原子的杂环环,N为1至4的整数),X代表卤原子,这些衍生物可用作中间体.这项发明还涉及制备这些衍生物的方法.

    海关参考信息

    专利信息


    专利号:US-9757463-B2
    优先权日:2012-06-15
    标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
    发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M
    权利人:UNIV VANDERBILT
    摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-8912150-B2
    优先权日:2001-08-03
    标题:Ribosome structure and protein synthesis inhibitors
    发明人:STEITZ THOMAS A; MOORE PETER B; SUTCLIFFE JOYCE A; OYELERE ADEGBOYEGA K; IPPOLITO JOSEPH A
    权利人:RIB X PHARMACEUTICALS INC; UNIV YALE; MELINTA THERAPEUTICS INC
    摘要:The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

    专利号:US-6947844-B2
    优先权日:2000-08-09
    标 题 :Modulators of ribosomal function and identification thereof
    发明人:STEITZ THOMAS A; MOORE PETER B; BAN NENAD; NISSEN POUL; HANSEN JEFFREY
    权利人:UNIV YALE
    摘要:The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

    专利号:US-6952650-B2
    优先权日:2001-08-03
    标题:Modulators of ribosomal function and identification thereof
    发明人:STEITZ THOMAS A; MOORE PETER B; BAN NENAD; NISSEN POUL; HANSEN JEFFREY
    权利人:UNIV YALE
    摘要:The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

    专利号:US-2007232495-A1
    优先权日:2006-03-24
    标题:Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof
    发明人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    权利人:NAPPA ALVARO O; LORENZINI FELIPE C; SANHUEZA ANDRES L
    摘要:The invention is related to compositions and methods that naturally protect plant tissues against ultraviolet radiation and temperature, thus giving protection against sunburn to plants, plant parts, fruits and/or flowers during their development. The invention is also related to compositions and methods to naturally improve the color of plants, plant parts, fruits and/or flowers by inducing the natural synthesis of flavonoids and anthocyanins present in plants. Likewise, the present invention is directed to improving the nutritional value of plants, plant parts, fruits and/or flowers by increasing the normal levels of polyphenolic compounds, especially flavonoids, present therein. Additionally, the present invention is related to compositions and methods that give more resistance to plants, plant parts, fruits and/or flowers against pathogens as bacteria and fungi. Finally, the present invention is related to plants, plant parts, fruits, flowers and/or propagating material treated with the compositions described in the present document.

    专利号:US-12036300-B2
    优先权日:2021-03-31
    标题:Methods and compositions for improving skin
    发明人:LIAO I-CHIEN; BRIEVA PATRICIA; JUCHAUX FRANCK; BOUEZ CHARBEL; ZHENG QIAN; QIAN KUN
    权利人:OREAL
    摘要:A method for managing skin tone comprising reducing the synthesis of melanin by applying a skin treatment composition to skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Tang HC, Lam WP, Zhang X, Leung PC, Yew DT, Liang W. Short-Term Flavoxate Treatment Alters Detrusor Contractility Characteristics: Renewed Interest in Clinical Use? Low Urin Tract Symptoms. 2015 Sep;7(3):149-54. doi: 10.1111/luts.12063. Epub 2014 Jun 3. doi: 10.1007/s00192-014-2585-5. Epub 2014 Dec 6. Review. doi: 10.1016/j.saa.2014.06.058. Epub 2014 Jun 20. doi: 10.1016/j.juro.2014.04.092. Epub 2014 Apr 30. Epub 2011 Feb 15.
    8: Attimarad M. Liquid Chromatographic Determination of Flavoxate HCl in Pharmaceutical Formulation. J Young Pharm. 2010 Jul;2(3):280-3. doi: 10.4103/0975-1483.66787.
    9: Mohammed ZS, Simi ZU, Tariq SM, Ali KR. Bilateral acute angle closure glaucoma in a 50 year old female after oral administration of flavoxate. Br J Clin Pharmacol. 2008 Nov;66(5):726-7. doi: 10.1111/j.1365-2125.2008.03254.x. Epub 2008 Jul 8.

    合成参考文献


    摘要:S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (2021) DOI:10.1021/acsenvironau.1c00008. List downloaded from
    参考文献:10.1007/pl00007835
    摘要:Fernández O. Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J Neurol. 2002 Jan;249(1):1–8. doi: 10.1007/pl00007835.
    参考文献:10.1007/s00192-004-1133-0
    摘要:Kinchen KS, Long S, Orsini L, Crown W, Bump RC. Healthcare utilization among women who undergo surgery for stress urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction. 2004 Jun 01;15(3):154–9. doi: 10.1007/s00192-004-1133-0.
    参考文献:10.2147/tcrm.1.2.157.62912
    摘要:Guay DR. Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence. Ther Clin Risk Manag. 2005 Jun;1(2):157–67.
    参考文献:10.1016/j.ijcard.2007.12.075
    摘要:Patanè S, Marte F, Di Bella G, Chiofalo S, Currò A, Coglitore S. Acute myocardial infarction and Kounis syndrome. International Journal of Cardiology. 2009 May;134(2):e45–6. doi: 10.1016/j.ijcard.2007.12.075.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知